about
Childhood immune thrombocytopenia: Clinical presentation and managementZika virus (ZIKV) infection related with immune thrombocytopenic purpura (ITP) exacerbation and antinuclear antibody positivityThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisInflammation induces hemorrhage in thrombocytopenia.Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia.Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia.New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review.Gene expression and pathway analysis of immune thrombocytopenic purpura.Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.Drug-induced immune thrombocytopenic purpura secondary to sunitinib.Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura.The expression of IFN-gamma, IL-4, Foxp3 and perforin genes are not correlated with DNA methylation status in patients with immune thrombocytopenic purpura.Genetic studies in pediatric ITP: outlook, feasibility, and requirements.Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.ITP: a historical perspective.Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP).CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.Bmi-1 regulates autoreactive CD4+ T cell survival in immune thrombocytopenia patients.Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.CD4+ CD25+High Foxp3+ regulatory T cells, B lymphocytes, and T lymphocytes in patients with acute ITP in Assiut Children Hospital.The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesProteomics-based identification of haptoglobin as a favourable serum biomarker for predicting long-term response to splenectomy in patients with primary immune thrombocytopeniaEfficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice.B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopeniaValue of vanin-1 assessment in adult patients with primary immune thrombocytopenia.Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopeniaAntiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding.Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children.Romiplostim as early treatment for refractory primary immune thrombocytopenia.Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.Effect of steroids on the activation status of platelets in patients with Immune thrombocytopenia (ITP).The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.Increased interleukin-27 promotes Th1 differentiation in patients with chronic immune thrombocytopenia.Expression of IL4 (VNTR intron 3) and IL10 (-627) genes polymorphisms in childhood immune thrombocytopenic purpura.
P2860
Q27023294-A4425873-9673-405F-AB4D-C1CCBFE4EF18Q27108164-DBD53446-EE24-4652-8500-F4ED17D6A22FQ28068881-02E51B0B-CBAB-4CAA-AA5A-08EA3E640DBAQ30481913-343BCF3A-1A8C-4C58-9D8F-0634E856B273Q33376011-7E67A522-2500-4474-94ED-756BDD839B68Q33376412-7F17C09A-8883-4CFF-8932-0FB7DF3268BBQ33377221-BED1F603-31BA-46DB-B50D-195E0A99B525Q33377373-F7509F3E-4B03-4D3F-B91A-FD7FC0ECED2AQ33378585-B98675F3-D585-4670-967F-CAC542F237F4Q33380172-07FCBBD3-4893-4728-BD99-1DB83DCB6921Q33382854-376EFEF2-8AB4-4476-93EC-9BC6EAF73F8DQ33385389-C12D7EA1-07D9-49E5-9E18-266016A85BBBQ33386823-87DC7EE4-C524-448E-B335-3C840737022DQ33387962-B267CE97-B3A8-4629-819A-7EA2089A139AQ33388868-AA75B306-4DD4-45EB-B4A8-3FB701AB5ADCQ33391987-A9320147-DEC4-4BED-A8FF-933568F00F5BQ33394791-0EABF2B3-59EC-4D31-996B-B3FE043F0F6DQ33396043-39DA51F0-4F77-435A-A427-B5F7DC42F231Q33396602-A0115BAB-74F8-4E94-AFE1-1CE7200B04DFQ33398815-21332B3C-6E2A-493C-8819-B34F6B0CFE1AQ33399426-FDB11613-4845-4024-A4FD-7C6ED450BE85Q33402453-C670AEFC-8AD8-4E6C-8468-AA1A490839D6Q33402738-2F8DF350-82B1-4380-B3FA-103BD5F6CF59Q33403270-F93F5EB0-200E-4F1B-8D0A-9C06DA19BEC6Q33403517-375D4BA6-70B4-416A-80C8-153EE079FE2BQ33403688-7809BBC7-9C41-4C81-B8C2-31E2A6BEC79CQ33404032-35E19507-7E88-477E-914C-7DB5EC4870C0Q33404838-C547EB86-3472-4217-B305-181FB13ED42EQ33406127-028C31A4-3B93-49E9-9F49-E5BB2D54D7D4Q33406674-810F00DF-85EC-4953-9D93-15A897D96A03Q33407451-AF3C51C5-3046-4F70-A887-33736F40D6A3Q33409515-875FEF54-5AD5-49B8-9BBF-7CF1BE1D6B77Q33410356-881A9315-7E49-4063-A363-23C04A8F8365Q33410572-D6AE723B-1230-48EE-A912-870D110E8968Q33413287-494C3332-0CC9-417D-9110-640B195C0633Q33413528-F7EB88D0-D7AF-404B-BFAF-1F344F50500AQ33413853-5C9EC4FC-2E39-417A-A578-927CE4CD5AC3Q33414420-BBB0CAB8-C59F-432E-989E-272BD8B11321Q33415798-32F06499-8791-49C1-92AE-4CFB32F6244DQ33416633-A71A7D61-5A9B-4408-8163-69CB095B3686
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The pathogenesis of immune thrombocytopaenic purpura
@ast
The pathogenesis of immune thrombocytopaenic purpura
@en
The pathogenesis of immune thrombocytopaenic purpura
@nl
type
label
The pathogenesis of immune thrombocytopaenic purpura
@ast
The pathogenesis of immune thrombocytopaenic purpura
@en
The pathogenesis of immune thrombocytopaenic purpura
@nl
prefLabel
The pathogenesis of immune thrombocytopaenic purpura
@ast
The pathogenesis of immune thrombocytopaenic purpura
@en
The pathogenesis of immune thrombocytopaenic purpura
@nl
P2860
P3181
P1476
The pathogenesis of immune thrombocytopaenic purpura
@en
P2093
Nichola Cooper
P2860
P304
P3181
P356
10.1111/J.1365-2141.2006.06024.X
P407
P577
2006-05-01T00:00:00Z